Renalytix
Salim Hamir is an accomplished finance professional with extensive experience in consultancy and corporate governance. As Director at Simba Partners since April 2010, Salim provides a range of services including CFO, FD, and Company Secretary functions, along with strategic advice on M&A and fundraising, especially for listings on the London Stock Exchange (AIM). Additional roles include Board Secretary for Renalytix and Verici Dx, where Salim contributed to significant fundraising initiatives, and serving as CFO and Board Secretary for Trellus Health. Previous positions encompass leadership roles in EKF Diagnostics, Hostmaker, and Quotient Diagnostics, highlighting a strong background in financial oversight, compliance, and corporate affairs. Salim's expertise is further enhanced by experiences in risk management and change management across various sectors.
This person is not in any teams
This person is not in any offices
Renalytix
Renalytix (LSE: RENX) (NASDAQ: RNLX) is the founder and global leader in the new field of bioprognosis™ for kidney health.